Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Pharmaceutical Co., Ltd. (ZPHC) is a Chinese pharmaceutical manufacturer founded in 1972 and headquartered in Zhengzhou, Henan. The company specializes in the development and production of semi-synthetic antibiotics, androgenic anabolic steroids (AAS), and various hormones. Operating from a large-scale facility exceeding 6,000 square meters, ZPHC employs over 2,000 professionals and maintains GMP-certified production standards. While it serves the general healthcare market with anti-infectives and APIs, the company is globally recognized for its extensive portfolio of performance-enhancing compounds used in professional sports and bodybuilding. ZPHC utilizes advanced laboratories for quality control and provides a robust anti-counterfeiting verification system for its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Pharmaceutical.